What if AI could match cancer patients with the right treatments faster—bringing precision medicine to more people who need it?

Rick Fultz, CEO of Acurion, is using artificial intelligence to transform how we select cancer therapies, moving beyond traditional biomarkers to comprehensive patient profiling.

🎙️ Full episode drops October 30

In the complete interview, we dive into:


How AI is revolutionizing cancer treatment selection

Moving beyond traditional biomarker approaches

Fundraising and building investor confidence

Scaling precision medicine


Subscribe so you don't miss it.

#SneakPeek #PrecisionMedicine #AI #Cancer

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Jeff Trickett. Innehållet i podden är skapat av Jeff Trickett och inte av, eller tillsammans med, Poddtoppen.